CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 59 filers reported holding CARDIFF ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,434 | -5.4% | 18,298 | 0.0% | 0.01% | -40.0% |
| Q2 2023 | $26,898 | -10.9% | 18,298 | 0.0% | 0.01% | -37.5% |
| Q1 2023 | $30,192 | +17.9% | 18,298 | 0.0% | 0.02% | +23.1% |
| Q4 2022 | $25,617 | -8.5% | 18,298 | 0.0% | 0.01% | +30.0% |
| Q3 2022 | $28,000 | -62.2% | 18,298 | -45.9% | 0.01% | -68.8% |
| Q2 2022 | $74,000 | -11.9% | 33,798 | 0.0% | 0.03% | -17.9% |
| Q1 2022 | $84,000 | – | 33,798 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $15,158,000 | 12.39% |
| Octagon Capital Advisors LP | 982,753 | $5,906,000 | 1.15% |
| Altium Capital Management LP | 337,000 | $2,025,000 | 0.56% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $616,000 | 0.44% |
| Eventide Asset Management | 1,670,399 | $10,039,000 | 0.13% |
| Artal Group S.A. | 750,000 | $4,508,000 | 0.12% |
| Aquatic Capital Management LLC | 8,000 | $48,000 | 0.09% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 17,300 | $104,000 | 0.06% |
| Anson Funds Management LP | 69,381 | $417,000 | 0.04% |
| KENNEDY CAPITAL MANAGEMENT LLC | 170,447 | $1,024,000 | 0.02% |